# Dare Bioscience, Inc.: filings

DARE · Nasdaq · CIK 1401914 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dare.md) · [Financials](/companies/dare/financials.md) · [Filings](/companies/dare/filings.md) · [Insiders](/companies/dare/insiders.md)

## Reports and events: 319 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 220, 4 196, 3 39, 10-Q 38, DEFA14A 26, CORRESP 23, 424B5 22, UPLOAD 17, SC 13G/A 15, EFFECT 14, 10-K 12, D 12, DEF 14A 12, S-8 11, SC 13D/A 10, SC 13G 10, 424B3 8, SC 13D 8, CT ORDER 7, S-3 7, S-1 6, S-1/A 6, ARS 5, PRE 14A 5, 253G2 4, 10-K/A 3, 8-K/A 3, SCHEDULE 13G 3, 424B4 2, 4/A 2, FWP 2, POS AM 2, PRER14A 2, QUALIF 2, SEC STAFF LETTER 2, 10-Q/A 1, 1-A 1, 1-A/A 1, 1-A POS 1, 253G1 1, 3/A 1, 8-A12B 1, CERTNAS 1, D/A 1, DEFM14A 1, DFAN14A 1, DRS 1, PREM14A 1, S-3/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 17:00 ET | [DEF 14A](/filings/0001493152-26-045977.md) | Proxy statement, period 2026-10-06 | 0001493152-26-045977 |
| 2026-10-02 | 16:01 ET | [8-K](/filings/0001401914-26-000052.md) | 3.01 Delisting notice | 0001401914-26-000052 |
| 2026-10-01 | 09:00 ET | [8-K](/filings/0001493152-26-045275.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045275 |
| 2026-09-11 | 16:29 ET | [8-K](/filings/0001401914-26-000050.md) | 5.03 Amendment to articles or bylaws | 0001401914-26-000050 |
| 2026-09-09 | 09:00 ET | [8-K](/filings/0001493152-26-041904.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041904 |
| 2026-08-26 | 17:15 ET | [S-1](/filings/0001493152-26-040265.md) | Registration statement | 0001493152-26-040265 |
| 2026-08-17 | 08:35 ET | [8-K](/filings/0001493152-26-038649.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038649 |
| 2026-08-13 | 16:02 ET | [8-K](/filings/0001493152-26-037737.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037737 |
| 2026-08-13 | 16:02 ET | [10-Q](/filings/0001401914-26-000043.md) | Quarterly report, period 2026-06-30 | 0001401914-26-000043 |
| 2026-07-24 | 09:00 ET | [8-K](/filings/0001493152-26-034483.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034483 |
| 2026-07-17 | 16:07 ET | [8-K](/filings/0001401914-26-000040.md) | 3.01 Delisting notice | 0001401914-26-000040 |
| 2026-07-13 | 09:00 ET | [8-K](/filings/0001493152-26-032963.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032963 |
| 2026-06-22 | 09:00 ET | [8-K](/filings/0001493152-26-029515.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029515 |
| 2026-06-12 | 16:01 ET | [8-K](/filings/0001401914-26-000032.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001401914-26-000032 |
| 2026-05-18 | 16:25 ET | [8-K](/filings/0001401914-26-000030.md) | 3.02 Unregistered sale of equity | 0001401914-26-000030 |
| 2026-05-14 | 16:03 ET | [10-Q](/filings/0001401914-26-000026.md) | Quarterly report, period 2026-03-31 | 0001401914-26-000026 |
| 2026-05-14 | 16:01 ET | [8-K](/filings/0001401914-26-000025.md) | 2.02 Results of operations | 0001401914-26-000025 |
| 2026-05-07 | 16:11 ET | [8-K](/filings/0001401914-26-000021.md) | 3.02 Unregistered sale of equity | 0001401914-26-000021 |
| 2026-04-28 | 16:02 ET | [DEF 14A](/filings/0001401914-26-000014.md) | Proxy statement, period 2026-06-11 | 0001401914-26-000014 |
| 2026-04-22 | 09:00 ET | [8-K](/filings/0001493152-26-018460.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018460 |
| 2026-04-20 | 16:07 ET | [8-K](/filings/0001401914-26-000012.md) | 3.02 Unregistered sale of equity | 0001401914-26-000012 |
| 2026-04-17 | 16:10 ET | [8-K](/filings/0001401914-26-000010.md) | 5.02 Departure or appointment of officers or directors | 0001401914-26-000010 |
| 2026-04-13 | 16:58 ET | [8-K](/filings/0001401914-26-000006.md) | 3.02 Unregistered sale of equity | 0001401914-26-000006 |
| 2026-03-26 | 16:02 ET | [10-K](/filings/0001401914-26-000004.md) | Annual report, period 2025-12-31 | 0001401914-26-000004 |
| 2026-03-26 | 16:01 ET | [8-K](/filings/0001493152-26-012902.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012902 |
| 2026-03-17 | 16:37 ET | [8-K](/filings/0001493152-26-010594.md) | 3.02 Unregistered sale of equity | 0001493152-26-010594 |
| 2026-03-09 | 16:05 ET | [8-K](/filings/0001493152-26-009364.md) | 3.02 Unregistered sale of equity | 0001493152-26-009364 |
| 2026-03-02 | 08:01 ET | [8-K](/filings/0001493152-26-008451.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008451 |
| 2026-01-29 | 17:00 ET | [8-K](/filings/0001493152-26-004245.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-004245 |
| 2026-01-06 | 08:01 ET | [8-K](/filings/0001493152-26-000513.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000513 |
| 2025-12-01 | 08:01 ET | [8-K](/filings/0001493152-25-025491.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025491 |
| 2025-11-13 | 16:03 ET | [10-Q](/filings/0001401914-25-000050.md) | Quarterly report, period 2025-09-30 | 0001401914-25-000050 |
| 2025-11-13 | 16:01 ET | [8-K](/filings/0001493152-25-022277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022277 |
| 2025-09-02 | 08:00 ET | [8-K](/filings/0001493152-25-012516.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012516 |
| 2025-08-14 | 16:04 ET | [10-Q](/filings/0001401914-25-000044.md) | Quarterly report, period 2025-06-30 | 0001401914-25-000044 |
| 2025-08-14 | 16:01 ET | [8-K](/filings/0001641172-25-023971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023971 |
| 2025-07-25 | 08:00 ET | [8-K](/filings/0001493152-25-011402.md) | 8.01 Other events | 0001493152-25-011402 |
| 2025-07-21 | 17:48 ET | [8-K](/filings/0001641172-25-020295.md) | 8.01 Other events | 0001641172-25-020295 |
| 2025-07-14 | 08:01 ET | [8-K](/filings/0001641172-25-018894.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018894 |
| 2025-07-09 | 16:05 ET | [8-K](/filings/0001641172-25-018393.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-018393 |
| 2025-06-25 | 08:00 ET | [8-K](/filings/0001641172-25-016374.md) | 8.01 Other events | 0001641172-25-016374 |
| 2025-06-09 | 08:00 ET | [8-K](/filings/0001641172-25-014238.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014238 |
| 2025-05-13 | 16:04 ET | [10-Q](/filings/0001401914-25-000022.md) | Quarterly report, period 2025-03-31 | 0001401914-25-000022 |
| 2025-05-13 | 16:01 ET | [8-K](/filings/0001641172-25-009939.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009939 |
| 2025-04-24 | 16:02 ET | [DEF 14A](/filings/0001401914-25-000014.md) | Proxy statement, period 2025-06-12 | 0001401914-25-000014 |
| 2025-04-11 | 17:15 ET | [8-K](/filings/0001641172-25-003887.md) | 8.01 Other events | 0001641172-25-003887 |
| 2025-03-31 | 16:01 ET | [10-K](/filings/0001401914-25-000012.md) | Annual report, period 2024-12-31 | 0001401914-25-000012 |
| 2025-03-31 | 16:01 ET | [8-K](/filings/0001641172-25-001682.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001682 |
| 2025-02-14 | 17:10 ET | [8-K](/filings/0001493152-25-006958.md) | 3.01 Delisting notice | 0001493152-25-006958 |
| 2025-02-10 | 08:01 ET | [8-K](/filings/0001493152-25-005533.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005533 |

Page 1 of 7. [Older](/companies/dare/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:00 ET. No prices; not investment advice.